REFERENCES
Arjona, A., Barquero, N., Doménech,
A., Tejerizo, G., Collado, V. M., Toural, C., . . . Gomez-Lucia, E.
(2007). Evaluation of a novel nested PCR for the routine diagnosis of
feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV).Journal of Feline Medicine and Surgery, 9 (1), 14-22.
Bande, F., Arshad, S. S., Hassan, L.,
Zakaria, Z., Sapian, N. A., Rahman, N. A., & Alazawy, A. (2012).
Prevalence and risk factors of feline leukaemia virus and feline
immunodeficiency virus in peninsular Malaysia. BMC veterinary
research, 8 (1), 33.
Barr, M. C., Pough, M. B., Jacobson,
R. H., & Scott, F. W. (1991). Comparison and interpretation of
diagnostic tests for feline immunodeficiency virus infection.Journal of the American Veterinary Medical Association, 199 (10),
1377-1381.
Bendinelli, M., Pistello, M.,
Lombardi, S., Poli, A., Garzelli, C., Matteucci, D., . . . Tozzini, F.
(1995). Feline immunodeficiency virus: an interesting model for AIDS
studies and an important cat pathogen. Clinical microbiology
reviews, 8 (1), 87-112.
Berger, A., Willi, B., Meli, M. L.,
Boretti, F. S., Hartnack, S., Dreyfus, A., . . . Hofmann-Lehmann, R.
(2015). Feline calicivirus and other respiratory pathogens in cats with
Feline calicivirus-related symptoms and in clinically healthy cats in
Switzerland. BMC veterinary research, 11 (1), 282.
Binns, S., Dawson, S., Speakman, A.,
Cuevas, L., Hart, C., Gaskell, C., . . . Gaskell, R. (2000). A study of
feline upper respiratory tract disease with reference to prevalence and
risk factors for infection with feline calicivirus and feline
herpesvirus. Journal of Feline Medicine & Surgery, 2 (3),
123-133.
Blanco, K., Prendas, J., Corte, R.,
Jimenez, C., & Dolz, G. (2009). Seroprevalence of viral infections in
domestic cats in Costa Rica. 71 (5), 661.
Chang, H. W., de Groot, R. J.,
Egberink, H. F., & Rottier, P. J. (2010). Feline infectious
peritonitis: insights into feline coronavirus pathobiogenesis and
epidemiology based on genetic analysis of the viral 3c gene . Journal of
General Virology.
Chen, D. (2013). Diagnosis and
Treatment of Feline Viral Rhinotracheitis in South China Tigers(Panthera
tigris amoyensis). Chinese Journal of Wildlife .
Cong, W., Meng, Q.-F., Blaga, R.,
Villena, I., Zhu, X.-Q., & Qian, A.-D. (2016). Toxoplasma gondii,
Dirofilaria immitis, feline immunodeficiency virus (FIV), and feline
leukemia virus (FeLV) infections in stray and pet cats (Felis catus) in
northwest China: co-infections and risk factors. Parasitology
research, 115 (1), 217-223.
Dall’Ara, P., Labriola, C., Sala, E.,
Spada, E., Magistrelli, S., & Lauzi, S. (2019). Prevalence of serum
antibody titres against feline panleukopenia, herpesvirus and
calicivirus infections in stray cats of Milan, Italy. Preventive
veterinary medicine, 167 , 32-38.
Dorny, P., Speybroeck, N.,
Verstraete, S., Baeke, M., De Becker, A., Berkvens, D., & Vercruysse,
J. (2002). Serological survey Toxoplasma gondii of a on feline
immunodeficiency virus and feine leukaemia virus in urban stray cats in
Belgium. Veterinary Record, 151 (21), 626-629.
Eckstrand, C. D., Sparger, E. E., &
Murphy, B. G. (2017). Central and peripheral reservoirs of feline
immunodeficiency virus in cats: a review. 98 (8), 1985-1996.
Filoni, C., Catão-Dias, J. L.,
Cattori, V., Willi, B., Meli, M. L., Corrêa, S. H. R., . . . Marvulo, M.
F. V. (2012). Surveillance using serological and molecular methods for
the detection of infectious agents in captive Brazilian neotropic and
exotic felids. Journal of Veterinary Diagnostic Investigation,
24 (1), 166-173.
Gao, Y. W., Xia, X. Z., Rong_Liang,
H. U., Huang, G., Chun_Zhong, X. U., & Wang, T. D. (2003).
Characterization and hypervariable region analysis of two feline
calicivirus isolates from cheetah and tiger. Chinese Journal of
Preventive Veterinary Medicine .
Gates, M., Vigeant, S., & Dale, A.
(2017). Prevalence and risk factors for cats testing positive for feline
immunodeficiency virus and feline leukaemia virus infection in cats
entering an animal shelter in New Zealand. New Zealand veterinary
journal, 65 (6), 285-291.
Gleich, S. E., Krieger, S., &
Hartmann, K. (2009). Prevalence of feline immunodeficiency virus and
feline leukaemia virus among client-owned cats and risk factors for
infection in Germany. Journal of Feline Medicine and Surgery,
11 (12), 985-992.
Levy, J. K., Scott, H. M., Lachtara,
J. L., & Crawford, P. C. (2006). Seroprevalence of feline leukemia
virus and feline immunodeficiency virus infection among cats in North
America and risk factors for seropositivity. Journal of the
American Veterinary Medical Association, 228 (3), 371-376.
Li, C., Liu, Q., Kong, F., Guo, D.,
Zhai, J., Su, M., & Sun, D. (2019). Circulation and genetic diversity
of Feline coronavirus type I and II from clinically healthy and
FIP‐suspected cats in China. Transboundary and emerging diseases,
66 (2), 763-775.
Luckman, C., & Gates, M. C. (2017).
Epidemiology and clinical outcomes of feline immunodeficiency virus and
feline leukaemia virus in client-owned cats in New Zealand.Journal of Feline Medicine and Surgery Open Reports, 3 (2),
2055116917729311.
Lutz, H., Addie, D., Belák, S.,
Boucraut-Baralon, C., Egberink, H., Frymus, T., . . . Lloret, A. (2009).
Feline leukaemia. ABCD guidelines on prevention and management.Journal of Feline Medicine & Surgery, 11 (7), 565-574.
Malik, R., Kendall, K., Cridland, J.,
Coulston, S., Stuart, A., Snow, D., & Love, D. (1997). Prevalences of
feline leukaemia virus and feline immunodeficiency virus infections in
cats in Sydney. Australian Veterinary Journal, 75 (5), 323-327.
Nakamura, Y., Nakamura, Y., Ura, A.,
Hirata, M., Sakuma, M., Sakata, Y., . . . Endo, Y. (2010). An updated
nation-wide epidemiological survey of feline immunodeficiency virus
(FIV) infection in Japan. Journal of Veterinary Medical Science ,
1003030181-1003030181.
Niu, J. T., Yi, S. S., Hu, G. X.,
Guo, Y. B., Zhang, S., Dong, H., . . . Wang, K. (2018). Prevalence and
molecular characterization of parvovirus in domestic kittens from
Northeast China during 2016-2017. Japanese Journal of Veterinary
Research, 66 (3), 145-155.
Norris, J. M., Bell, E. T., Hales,
L., Toribio, J.-A. L., White, J. D., Wigney, D. I., . . . Malik, R.
(2007). Prevalence of feline immunodeficiency virus infection in
domesticated and feral cats in eastern Australia. Journal of
Feline Medicine and Surgery, 9 (4), 300-308.
Pan, M.-q., Wang, J.-c., & Wang,
Y.-j. (2018). The prevalence and genetic diversity of feline
immunodeficiency virus and feline leukemia virus among stray cats in
Harbin, China. Turkish Journal of Zoology, 42 (2), 245-251.
Pedersen, N. (1983). Feline
infectious peritonitis and feline enteric coronavirus infections. 1.
Feline enteric coronaviruses [Cats]. Feline Practice (USA) .
Phillips, T. R., Lamont, C., Konings,
D. A. M., Shacklett, B. L., & Elder, J. H. (1992). Identification of
the Rev transactivation and Rev–responsive elements of feline
immunodeficiency virus. Journal of Virology, 66 (9), 5464-5471.
Qiu, W., Xia, X., Fan, Q., He, H.,
Huang, G., Yu, C., . . . Wang, C. (2000). Isolation and identification
of tiger’s feline panleukopenia virus. Chinese Journal of
Preventive Veterinary Medicine, 22 (4), 249-251.
Reese, M. J., Patterson, E. V.,
Tucker, S. J., Dubovi, E. J., Davis, R. D., Crawford, P. C., & Levy, J.
K. (2008). Effects of anesthesia and surgery on serologic responses to
vaccination in kittens. Journal of the American Veterinary Medical
Association, 233 (1), 116-121.
Tekes, G., & Thiel, H.-J. (2016).
Feline coronaviruses: pathogenesis of feline infectious peritonitis. InAdvances in virus research (Vol. 96, pp. 193-218): Elsevier.
Wang, J., Wei, L., Rui, F. U., Li, X.
B., Wang, S. J., Gong, W., . . . Zheng-Ming, H. E. (2014). Establishment
and Preliminary Application of ELISA for Detecting Antibody to Felid
Herpesvirus 1 in Cat. Laboratory Animal Science .
Xu, C.-C., Shi-Ling, H. U., Chen, S.
J., Liu, C. G., Liu, Y., & Yan-Li, L. (2017). Epidemiologicin vestigate
of feline FHV and FCV infection in Beijing. Chinese Journal of
Veterinary Medicine .
Yang, S., Xia, X., Qiao, J., Liu, Q.,
Chang, S., Xie, Z., . . . Gao, Y. (2008). Complete protection of cats
against feline panleukopenia virus challenge by a recombinant canine
adenovirus type 2 expressing VP2 from FPV. Vaccine, 26 (11),
1482-1487.